Allogene Therapeutics Company
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Technology:
CAR-T, CAR-T therapy
Industry:
CAR-T, Public
Headquarters:
South San Francisco, California, United States
Founded Date:
2017-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
14
Total Funding:
531770409
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-09-07
Last Funding Type:
Convertible Note
Register and Claim Ownership